Genetic Technologies (ASX: GTG, NASDAQ Global Market: GENE) is a leader in the development and commercialisation of genetic risk assessment technology. We are a molecular diagnostics company that offers predictive testing and assessment tools to empower physicians to proactively manage patient health and individuals to manage and reduce their risk of contracting cancer and other chronic diseases.
Genetic Technologies (ASX: GTG, NASDAQ Global Market: GENE) is a leader in the development and commercialisation of genetic risk assessment technology. We are a molecular diagnostics company that offers predictive testing and assessment tools to empower physicians to proactively manage patient health and individuals to manage and reduce their risk of contracting cancer and other chronic diseases.